Research Projects (Third party funds)


European Infrastructure of Open Screening Platforms for Chemical Biology

EU-Openscreen 2012EU-OPENSCREEN, the European Infrastructure of Open Screening Platforms for Chemical Biology, integrates high- throughput screening platforms, chemical libraries, chemical resources for hit discovery and optimisation, bio- and cheminformatics support, and a database containing screening results, assay protocols, and chemical information.
These platforms – offering the most advanced technologies – will be used by European researchers from academia and SMEs in order to identify compounds affecting new targets. Open access to an integrated infrastructure for Chemical Biology will thus satisfy the needs for new bioactive compounds in many fields of the Life Sciences (e.g. human and veterinary medicine, systems biology, biotechnology, agriculture and nutrition).



Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM)

Institute of Molecular Genetics AS CR (IMG)

Technical University of Denmark (DTU)

European Molecular Biology Laboratory – Outstation European Bioinformatics Institute (EBI)

Institute for Molecular Medicine Finland (FIMM)

CNRS - Délégation Alsace

Leibniz-Institut für Molekulare Pharmakologie (FMP)

Helmholtz-Zentrum für Infektionsforschung (HZI)

Max Delbrück Center for Molecular Medicine (MDC)

Interdisciplinary Center for Biomolecular Studies and Industrial Applications (CISI)

IRBM for Collezione Nazionale di Composti Chimici e Centro Screening (CNCCS)

Biomedical Research Foundation, Acadamy of Athens (BRFAA)

Netherlands Cancer Institute (NKI)

Universitet i Oslo (UiO)

Institute of Medical Biology of PAS (IMB)

Fundacio Privada Parc Cientific de Barcelona (PCB)

Institute of Chemistry Timisoara of Romanian Academy (ICT)

Umeå University (UmU)

Universiteit Ghent


Ronald Frank


Foschungsverbund Berlin e.V. (FMP)(DE)

Funding agency


PrintSend per emailShare